One of the most aggressive and worst types of cancer is neuroendocrine carcinoma of colon
. The most negative part about the disease is that more often than not it is detected at the advanced stages when it is extremely hard to do anything about it.
As the symptoms of neuroendocrine colon cancer become visible only at very advanced stages, the rate of survival of the patient drops drastically The polyps or tumours of the colon are mostly detected with distant metastases. Surveys show the reports have revealed that most of the cases of neuroendocrine cancer result in death.
Though chances of neuroendocrine carcinoma in colon are rare at best if one is affected the health of the patient appears even worse than patients suffering from adenocarcinoma.
Researchers have showcased that the end results of this cancer do not differ with age, sex or tumour location. However, neuroendocrine colon carcinoma does depend on the stage of the tumour. Normal trends reveal that most people show that generally people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. Though in several cases, when the tumour is in stage 3 or 4, it is a laborious and difficult task the neuroendocrine colon carcinoma.
It is unfortunate that medical science has developed no adequate methods to deal with this particular cancer. One of the most popular methods that the doctors often use is immunohistochemical staining methods. this method assists the doctors to detect the severity of the neuroendocrine colon cancer and assists doctors in deciding on the most helpful medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. Involved in that, is the staining of the tumour with a monoclonal antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and nature of the damage on the patient's health.
Neuroendocrine colon carcinoma is difficult to treat and in a certain study in which several patients suffered from colon carcinoma were examined, it was observed that the average survival rate for this disease was approximately seven months. In a predominant stage these rates drop to less than five months Most cases were initially detected as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery may not be a guaranteed treatment so surgery may not even provide a satisfactory cure. Therefore it becomes necessary to make note of carcinoma as soon as possible and provide proper medication for it.